Nuvectis Pharma shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Nuvectis Pharma
Tip: Access up to 7 years of quarterly data
All positions including Nuvectis Pharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nuvectis Pharma by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $32k | 5.3k | 6.02 |
| 2025-03-31 | $1.7k | 179 | 9.77 |
| 2024-12-31 | $967 | 179 | 5.41 |
| 2024-09-30 | $1.2k | 192 | 6.31 |
| 2024-06-30 | $93k | 15k | 6.33 |
| 2024-03-31 | $42k | 5.2k | 8.20 |
| 2023-12-31 | $41k | 4.9k | 8.34 |
| 2023-09-30 | $63k | 4.9k | 12.89 |
| 2023-06-30 | $87k | 5.5k | 15.97 |